Human Epidermal Growth Factor Receptor 2 (HER2) Positive Unresectable Locally Advanced or Metastatic Breast Cancer Disease Registry Study
Clinical trial NCT02393924 · COMPLETED
Trial details
- NCT number
- NCT02393924
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-02-23
- Primary completion
- 2023-04-19
- Enrollment
- 311
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.